Jan 19, 2022

Commentary: To avoid the superbug pandemic, we must fix the antibiotics business

Posted by in categories: biotech/medical, business

Doctors must be careful when they consider treating their patients with the newest antibiotics, because every time these drugs are used, bacteria have a chance to build resistance. As a result, new antibiotics are generally used sparingly–leaving antibiotic companies with little chance of selling enough doses to recoup their investment.

If scientists don’t discover new antibiotics soon, the world will eventually return to the pre-antibiotic era when simple cuts could kill.

Comments are closed.